↓ Skip to main content
What is this page? Embed badge

Sleep-Wake Neurobiology and Pharmacology

Overview of attention for book
Sleep-Wake Neurobiology and Pharmacology
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 36 Adenosine and Sleep
  3. Altmetric Badge
    Chapter 37 Metabolite Clearance During Wakefulness and Sleep
  4. Altmetric Badge
    Chapter 40 Clinical Sleep–Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders
  5. Altmetric Badge
    Chapter 51 Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood
  6. Altmetric Badge
    Chapter 56 GABA Receptors and the Pharmacology of Sleep
  7. Altmetric Badge
    Chapter 84 Neuroanatomical and Neurochemical Bases of Vigilance States
  8. Altmetric Badge
    Chapter 87 The Role of Glia in Sleep Regulation and Function
  9. Altmetric Badge
    Chapter 94 Optogenetic Dissection of Sleep-Wake States In Vitro and In Vivo
  10. Altmetric Badge
    Chapter 95 Dopamine and Wakefulness: Pharmacology, Genetics, and Circuitry
  11. Altmetric Badge
    Chapter 125 Omics Approaches in Sleep-Wake Regulation
  12. Altmetric Badge
    Chapter 126 Clinical Sleep-Wake Disorders I: Focus on Hypersomnias and Movement Disorders During Sleep
  13. Altmetric Badge
    Chapter 139 Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood
  14. Altmetric Badge
    Chapter 174 Sleep- and Wake-Like States in Small Networks In Vivo and In Vitro
  15. Altmetric Badge
    Chapter 175 Clinical and Experimental Human Sleep-Wake Pharmacogenetics
  16. Altmetric Badge
    Chapter 176 Functional Interactions Between Sleep and Circadian Rhythms in Learning and Learning Disabilities
  17. Altmetric Badge
    Chapter 183 Pharmacosynthetic Deconstruction of Sleep-Wake Circuits in the Brain
  18. Altmetric Badge
    Chapter 243 Sleep Physiology, Circadian Rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics
Attention for Chapter 243: Sleep Physiology, Circadian Rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics
Altmetric Badge

Mentioned by

twitter
5 X users

Readers on

mendeley
257 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Sleep Physiology, Circadian Rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics
Chapter number 243
Book title
Sleep-Wake Neurobiology and Pharmacology
Published by
Springer, Berlin, Heidelberg, June 2019
DOI 10.1007/164_2019_243
Pubmed ID
31254050
Book ISBNs
978-3-03-011270-7, 978-3-03-011272-1
Authors

Derk-Jan Dijk, Hans-Peter Landolt, Dijk, Derk-Jan, Landolt, Hans-Peter

View on publisher site

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 257 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Country Count As %
Unknown 257 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 11%
Student > Bachelor 25 10%
Student > Ph. D. Student 19 7%
Researcher 13 5%
Student > Postgraduate 9 4%
Other 25 10%
Unknown 139 54%
Readers by discipline Count As %
Medicine and Dentistry 25 10%
Neuroscience 23 9%
Nursing and Health Professions 15 6%
Agricultural and Biological Sciences 10 4%
Sports and Recreations 7 3%
Other 29 11%
Unknown 148 58%